Abstract
The phamacokinetic behavior of caffeine was compared in a group of eight healthy young men aged 20.5±2.0 years (mean ± SD), and in a group of eight healthy, elderly men aged 71.2±3.9 years. Each subject was given a 5 mg/kg dose of caffeine as either an aqueous oral solution or an intravenous infusion over 30 min using a randomized crossover design. Plasma and urine samples were collected for 24 hr following each dose and analyzed for caffeine content using high-performance liquid chromatography.
The peak times (tmax), peak concentrations (Cmax), and the percentage of the peroral dose systemically available, F(%), were essentially identical in both age groups, indicating that caffeine was absorbed rapidly and completely after peroral administration. These results also indicated that the first-pass metabolism observed in rats following the peroral administration of caffeine does not occur in either human group studied here. The elimination of caffeine during its terminal disposition phase was log-linear. Several between-group comparisons of other pharmacokinetic parameters were made. Although the average elimination rate constant was greater in the elderly, the difference did not reach statistical significance, possibly because of the considerable intersubject variability in the elimination rate of caffeine, with halflives ranging from 2.27 to 9.87 hr. The average apparent volume of distribution was significantly lower in the elderly subjects while the clearances were slightly, but not significantly, larger in the elderly subjects. It appears that most aspects of the pharmacokinetic behavior of caffeine are very similar in young and elderly men.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
J. F. Greden. Coffee, tea and you. The Sciences19:6–11 (1979).
J. M. Ritchie. Central nervous system stimulants, the xanthines. In: L. S. Goodman and A. Gilman (eds.),The Pharmacologic Basis of Therapeutics, fifth ed. Macmillan, New York, 1975, pp. 367–378.
D. A. Holloway. Drug problems in the geriatric patient.Drug Intell. Clin. Pharm. 8:332–342 (1974).
A. D. Bender. Pharmacodynamic principles of drug therapy in the aged.J. Am. Geriatr. Soc. 22:269–303 (1974).
J. W. Gorrod. Absorption, metabolism and excretion of drugs in geriatric subjects.Geront. Clin. 16:30–42 (1974).
E. J. Triggs and R. L. Nation. Pharmacokinetics in the aged: a review.J. Pharmacokin. Biopharm. 3:387–418 (1975).
J. Crooks, K. O'Malley, and I. H. Stevenson. Pharmacokinetics in the elderly.Clin. Pharmacokin. 1:280–296 (1976).
A. Aldridge, J. V. Aranda, and A. H. Neims. Caffeine metabolism in the newborn.Clin. Pharmacol. Ther. 25:447–453 (1979).
J. Axelrod and J. Reichenthal. The fate of caffeine in man and a method for its estimation in biological material.J. Pharmacol. Exp. Ther. 107:519–523 (1953).
H. H. Cornish and A. A. Christman. A study of the metabolism of theobromine, theophylline, and caffeine in man.J. Biol. Chem. 218:315–323 (1957).
W. D. Parsons and A. H. Neims. Effect of smoking on caffeine clearance.Clin. Pharmacol. Ther. 24:40–45 (1978).
J. M. Trang, J. Blanchard, K. A. Conrad, and G. G. Harrison. Effect of vitamin C on the pharmacokinetics of caffeine in elderly men.Am. J. Clin. Nutr. 35:487–494 (1982).
J. Blanchard, J. D. Mohammadi, and K. A. Conrad. Improved liquid-chromatographic determination of caffeine in plasma.Clin. Chem. 26:1351–1354 (1980).
J. Blanchard, J. D. Mohammadi, and J. M. Trang. Elimination of a potential interference in assay for plasma caffeine.clin. Chem. 27:637–639 (1981).
M. Jaffé, Ueber den niederschlag welchen pikrinsaure in normalem harn erzeugt und über eine neue reaction des kreatinins.Hoppe Seylers Z. Physiol. Chem. 10:391–400 (1886).
J. Blanchard, Plasma protein binding of caffeine in young and elderly men.J. Pharm. Sci.,71:1415–1418 (1982).
J. A. Nelder and R. Mead. A simplex method for function minimization.Computer J. 7:308–313 (1965).
J. H. Ottaway. Normalization in the fitting of data by iterative methods.Biochem. J. 134:729–736 (1973).
H. G. Boxenbaum; S. Riegelman, and R. M. Elashoff. Statistical estimations in pharmacokinetics.J. Pharmacokin. Biopharm. 2:123–148 (1974).
D. S. Riggs.The Mathematical Approach to Physiological Problems. Williams and Wilkins, Baltimore, 1963, p. 51.
M. Gibaldi and D. Perrier.Pharmacokinetics. Marcel Dekker, New York, 1975.
R. A. Upton, S. Riegelman, and L. B. Sheiner. Bioavailability assessment as influenced by changes in drug disposition. In: K. S. Albert (ed.),Drug Absorption and Disposition: Statistical Considerations. Am. Pharm. Assoc., Washington, D.C., 1980, pp. 77–85.
Anon.Scientific Tables, K. Diem and C. Lentner (eds.), Ciba-Geigy, Basel, 1970, p. 711.
M. Sheehan and P. Haythorn. Rapid gas-chromatographic determination of underivatized theophylline in whole blood.J. Chromatogr. 117:393–398 (1976).
M. A. Peat and T. A. Jennison. Analysis of theophylline in serum and whole blood samples by high-pressure liquid chromatography.J. Analyt. Toxicol. 1:204–207 (1977).
J. P. Kampmann and J. E. Molholm Hansen. Renal excretion of drugs. In:Drugs and the Elderly—Perspectives in Geriatric Clinical Pharmacology. University Park Press, Baltimore, 1979, pp. 77–87.
A. Aldridge, W. D. Parsons, and A. H. Neims. Stimulation of caffeine metabolism in the rat by 3-methylcholanthrene.Life Sci. 21:967–974 (1977).
R. Latini, M. Bonati, D. Castelli, and S. Garattini. Dose-dependent kinetics of caffeine in rats.Toxicol. Lett. 2:267–270 (1978).
S. Garattini. Third international caffeine workshop.Nutr. Rev. 39:183–191 (1981).
R. Latini, M. Bonati, E. Marzi, M. T. Tacconi, B. Sadurska, and A. Bizzi. Caffeine disposition and effects in young and one-year old rats.J. Pharm. Pharmacol. 32:596–599 (1980).
W. D. Parsons, J. V. Aranda, and A. H. Neims. Elimination of transplacentally acquired caffeine in full-term neonates.Pediatr. Res. 10:333 (1976).
J. V. Aranda, W. Gorman, E. W. Outerbridge, and A. H. Neims. Pharmacokinetic disposition of caffeine in premature neonates with apnea.Pediatr. Res. 11:414 (1977).
R. Newton, L. J. Broughton, M. J. Lind, P. J. Morrison, H. J. Rogers, and I. D. Bradbrook. Plasma and salivary pharmacokinetics of caffeine in man.Eur. J. Clin. Phamacol. 21:45–52 (1981).
M. Essam Fikry and M. H. Aboul-Wafa. Intestinal absorption in the old.Geront. Clin. 7:171–178 (1965).
D. P. Richey and A. D. Bender. Pharmacokinetic consequences of aging.Annu. Rev. Pharmacol. Toxicol. 17:49–65 (1977).
I. S. Edelman and J. Liebman. Anatomy of body water and electrolytes.Am. J. Med. 27:256–277 (1959).
J. V. Aranda, J. L. Brazier, A. T. Louridas, and B. I. Sasyniuk. Methylxanthine metabolism in the newborn infant. In: L. F. Soyka and G. P. Redmond (eds.),Drug Metabolism in the Immature Human. Raven Press, New York, 1981, pp. 183–198.
H. Wietholtz, M. Vogelin, M. J. Arnaud, J. Bircher, and R. Preisig. Assessment of the cytochrome P-448 dependent liver enzyme system by a caffeine breath test.Eur. J. Clin. Pharmacol. 21:53–59 (1981).
M. M. Callahan, R. S. Robertson, M. J. Arnaud, A. R. Branfman, M. F. McComish, and D. W. Yesair. Human metabolism of [l-methyl-14C]-and [2-14C] caffeine after oral administration.Drug Metab. Dispos. 10:417–423 (1982).
U. Klotz and G. R. Wilkinson. Hepatic elimination of drugs in the elderly. In: K. Kitani, (ed.),Liver and Aging. Elsevier/North Holland Biomedical Press, New York, 1978, pp. 367–380.
E. J. Antal, P. A. Kramer, S. A. Mercik, D. J. Chapron, and I. R. Lawson. Theophylline pharmacokinetics in advanced age.Br. J. Clin. Pharmacol. 12:637–645 (1981).
A. H. Neims. Third international caffeine workshop.Nutr. Rev. 39:183–191 (1981).
G. R. Wilkinson and D. G. Shand. A physiological approach to hepatic drug clearance.Clin. Pharmacol. Ther. 18:377–390 (1975).
D. G. Greenblatt, M. Divol Allen, J. S. Harmatz, and R. I. Shader. Diazepam disposition determinants.Clin. Pharmacol. Ther. 27:301–312 (1980).
J. G. Wagner. Simple model to explain effects of plasma protein binding and tissue binding to calculated volumes of distribution, apparent elimination rate constants and clearances.Eur. J. Clin. Pharmacol. 10:425–432 (1976).
R. E. Schneider, H. Bishop, R. A. Yates, C. P. Quarterman, and M. J. Kendall. Effect of age on plasma propranolol levels.Br. J. Clin. Pharmacol. 10:169–170 (1980).
D. G. Greenblatt and R. I. Shader. Effects of age and other drugs on benzodiazepine kinetics.Arzn. Forsch. 30:886–890 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blanchard, J., Sawers, S.J.A. Comparative pharmacokinetics of caffeine in young and elderly men. Journal of Pharmacokinetics and Biopharmaceutics 11, 109–126 (1983). https://doi.org/10.1007/BF01061844
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01061844